Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker NXTC
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 12,333 | $5.10 | $62.9K Buy | Form 4 ↗ |
| Nov 6, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 3,662 | $5.10 | $18.7K Buy | Form 4 ↗ |
| Nov 5, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 1,024 | $5.10 | $5,222 Buy | Form 4 ↗ |
| Oct 27, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 3,553 | $5.10 | $18.1K Buy | Form 4 ↗ |
| Oct 26, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 1,672 | $5.03 | $8,418 Buy | Form 4 ↗ |
| Oct 23, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 5,626 | $4.83 | $27.2K Buy | Form 4 ↗ |
| Aug 10, 2026 | Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. | NXTC NextCure, Inc. | Sale | 30,000 | $6.16 | $184.8K Sale | Form 4 ↗ |
| Jul 31, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 8,003 | $4.80 | $38.4K Buy | Form 4 ↗ |
| Jul 31, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 25,000 | $4.98 | $124.5K Buy | Form 4 ↗ |
| Jul 31, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 3,300 | $4.98 | $16.4K Buy | Form 4 ↗ |
| Jul 30, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 77,850 | $4.96 | $386.1K Buy | Form 4 ↗ |
| Jul 30, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 100,000 | $4.90 | $490.0K Buy | Form 4 ↗ |
| Jul 30, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 25,000 | $4.81 | $120.3K Buy | Form 4 ↗ |
| Jul 30, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 20,000 | $5.00 | $100.0K Buy | Form 4 ↗ |
| Jul 30, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 20,000 | $5.00 | $100.0K Buy | Form 4 ↗ |
| Jul 30, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 50,000 | $4.97 | $248.5K Buy | Form 4 ↗ |
| Jul 29, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 1,600 | $5.00 | $8,000 Buy | Form 4 ↗ |
| Jul 29, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 1,810 | $5.00 | $9,050 Buy | Form 4 ↗ |
| Jul 28, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 6,400 | $4.95 | $31.7K Buy | Form 4 ↗ |
| Jul 27, 2026 | ADAR1 Capital Management, LLC 10% owner | NXTC NextCure, Inc. | Buy | 7,798 | $5.00 | $39.0K Buy | Form 4 ↗ |
20 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:15 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances